The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of a phase II trial of intense androgen deprivation therapy prior to radical prostatectomy (RP) in men with high-risk localized prostate cancer (PC).
 
Rana R. McKay
Consulting or Advisory Role - Astellas Medivation; Bristol-Myers Squibb; Dendreon; Exelixis; Janssen; Novartis; Pfizer; Tempus
Research Funding - Bayer (Inst); Pfizer (Inst)
 
Wanling Xie
No Relationships to Disclose
 
Fiona M. Fennessy
No Relationships to Disclose
 
Zhenwei Zhang
No Relationships to Disclose
 
Rosina Lis
No Relationships to Disclose
 
Dana E. Rathkopf
Consulting or Advisory Role - AstraZeneca; Bayer; Genentech; Janssen
Research Funding - AstraZeneca (Inst); Celgene (Inst); Ferring (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Medivation (Inst); Millennium (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); TRACON Pharma (Inst)
 
Vincent Paul Laudone
No Relationships to Disclose
 
Glenn Bubley
No Relationships to Disclose
 
David Johnson Einstein
Research Funding - Bristol-Myers Squibb (Inst); Trovagene (Inst)
 
Peter Chang
No Relationships to Disclose
 
Andrew Wagner
Stock and Other Ownership Interests - Bristol-Myers Squibb; Roche/Genentech
Consulting or Advisory Role - Advance Medical
 
Mark A. Preston
No Relationships to Disclose
 
Kerry L. Kilbridge
No Relationships to Disclose
 
Steven Lee Chang
No Relationships to Disclose
 
Atish Dipankar Choudhury
Employment - LeMaitre Vascular (I)
Honoraria - Astellas Pharma; Bayer; Janssen; Journal of Clinical Pathways/Oncology Learning Network; OncLive
Consulting or Advisory Role - Clovis Oncology; Dendreon; Dendreon; MedaCorp
Research Funding - Bayer; Janssen (Inst)
Travel, Accommodations, Expenses - Genentech
 
Mark Pomerantz
Honoraria - Bayer
 
Quoc-Dien Trinh
No Relationships to Disclose
 
Adam S. Kibel
Honoraria - InSightec; Janssen; Merck; profound
Consulting or Advisory Role - Advantagene; Bristol-Myers Squibb
 
Mary-Ellen Taplin
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Celgene; Clovis Oncology; Guidepoint Global; Incyte; Janssen-Ortho; Merck; Pfizer; Progenics; Research to Practice; UpToDate
Consulting or Advisory Role - AstraZeneca; Bayer; Best Doctors, Inc; Clovis Oncology; Guidepoint Global; Incyte; Janssen-Ortho; Myovant Sciences; Pfizer; Research to Practice; UpToDate
Research Funding - Bayer (Inst); Janssen-Ortho (Inst); Medivation (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Clovis Oncology; Incyte; Janssen Oncology; Medivation; Pfizer; Tokai Pharmaceuticals